Collegium Pharmaceutical (COLL) Cash from Investing Activities Growth (3y) (2018 - 2026)
Collegium Pharmaceutical (COLL) Cash from Investing Activities Growth (3y) (2018 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.05 Bn | 43.08 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.39 Bn | 39.74 Bn | 2.15 Bn | -53.63% |
| 3 | Zoetis | 31.86 Bn | 30.18 Bn | 1.05 Bn | -55.36% |
| 4 | Takeda Pharmaceutical | 28.78 Bn | 22.99 Bn | 5.10 Bn | 34.35% |
| 5 | United Therapeutics | 22.25 Bn | 19.59 Bn | 683.80 Mn | 33.61% |
| 6 | Viatris | 18.74 Bn | 17.85 Bn | 1.46 Bn | 15.92% |
| 7 | Neurocrine Biosciences | 15.58 Bn | 15.19 Bn | 935.80 Mn | -2.45% |
| 8 | Elanco Animal Health | 11.92 Bn | 11.39 Bn | 798.00 Mn | -36.76% |
| 9 | Dr Reddys Laboratories | 10.16 Bn | 9.99 Bn | - | - |
| 10 | Collegium Pharmaceutical | 902.41 Mn | 753.09 Mn | 110.29 Mn | -129.25% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -129.25% |
| Mar 31, 2026 | 124.03% |
| Dec 31, 2025 | -177.42% |
| Sep 30, 2025 | -548.85% |
| Jun 30, 2025 | -84.92% |
| Mar 31, 2025 | 74.33% |
| Dec 31, 2024 | -183.72% |
| Sep 30, 2024 | -866.22% |
| Jun 30, 2024 | -130.74% |
| Mar 31, 2024 | -248.58% |
| Dec 31, 2023 | -156.86% |
| Sep 30, 2023 | -16.73% |
| Jun 30, 2023 | -165.03% |
| Mar 31, 2023 | 92.18% |
| Dec 31, 2022 | -1.88% |
| Sep 30, 2022 | 56.27% |
| Jun 30, 2022 | 19.23% |
| Mar 31, 2022 | -456.33% |
| Dec 31, 2021 | 33.77% |
| Sep 30, 2021 | 53.34% |